TrialClinical cancer research : an official journal of the American Association for Cancer Research2023

Palbociclib Rechallenge for Hormone Receptor-Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial.

Joan Albanell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.